The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

Johnson & Johnson Postpones Medical Devices & Diagnostics Review

Tuesday, October 30, 2012

Johnson & Johnson Postpones Medical Devices & Diagnostics Review10:43 EDT Tuesday, October 30, 2012NEW BRUNSWICK, N.J., Oct. 30, 2012  /PRNewswire/ -- Given the state of emergency in New Jersey due to Hurricane Sandy, Johnson & Johnson (NYSE: JNJ) announced that it will postpone the company's Medical Devices & Diagnostics business review for the investment community, which was scheduled for Thursday, Nov. 1st.  The company made the postponement decision to ensure the safety of its employees and expected attendees in the aftermath of the storm.  A new date for the business review will be scheduled for early 2013.About Johnson & JohnsonCaring for the world, one person at a time?inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 129,000 employees at more than 250 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.SOURCE Johnson & JohnsonFor further information: Press: Al Wasilewski, +1-732-524-1130 or Bill Price, +1-732-524-6623 or Investor Contacts: Louise Mehrotra, +1-732-524-6491, Stan Panasewicz, +1-732-524-2524, Lesley Fishman, +1-732-524-3922 or Ellen Sipos, +1-732-524-3709